首页 › 骨髓增生异常综合征 › 佛罗里达州 › Miami
Miami FL 骨髓增生异常综合征临床试验
17项针对 骨髓增生异常综合征的研究正在 Miami及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Miami Cancer Institute, Miami
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
招募中2 期
- Miami Cancer Institute, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
招募中1/2 期
- Sylvester Cancer Center - U Miami, Miami
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
招募中3 期
- University of Miami, Miami
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
招募中2 期欢迎健康志愿者
- University of Miami, Miami
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Nicklaus Children's Hospital, Miami
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
招募中3 期
- University of Miami Hospital and Clinics, Miami
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
招募中2 期
- University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC), Miami
eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
招募中
- University of Miami, Miami
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
招募中1/2 期
- University of Miami, Miami
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- University of Miami, Miami
- Miami Cancer Institute, Miami
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
招募中
- Sylvester Comprehensive Cancer Center, Miami
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
招募中1 期
- University of Miami Health System, Miami
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
招募中1 期
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Miami
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
招募中1 期
- Sylvester Comprehensive Cancer Center, Miami
其他城市的 骨髓增生异常综合征试验
- Houston, TX43 项研究
- Baldwin Park, CA26 项研究
- New York City, NY21 项研究
- Seattle, WA21 项研究
- Washington, DC20 项研究
- Tampa, FL19 项研究
- Boston, MA19 项研究
- Durham, NC14 项研究
- Columbus, OH14 项研究
- St. Louis, MO13 项研究
- Atlanta, GA13 项研究
- Chicago, IL13 项研究
Miami的其他研究
- 乳腺癌42 项研究
- 癌症（所有类型）36 项研究
- 非小细胞肺癌31 项研究
- 前列腺癌27 项研究
- 肥胖症27 项研究
- 急性髓系白血病24 项研究
- 转移性癌症23 项研究
- 超重23 项研究
- 卵巢癌23 项研究
- 溃疡性结肠炎21 项研究
- 多发性骨髓瘤21 项研究
- 阿尔茨海默病20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。